Pilot Study evaluating somatostatin receptor's PET imaging to detect inflammatory phases of myocarditis - DOTAMIR

CHRU DE NANCY0 个研究点目标入组 33 人开始时间: 2020年1月31日最近更新: 2020年6月22日

试验速览

暂无简介。

•- Major patient having received complete information on the organization of the research and having signed their informed consent.
•- Patient hospitalized for chest pain with positive troponins,
•- Patient with a high probability of acute inflammatory myocarditis on secondary MRI (= 2 Lake Louise criteria)
•- Person affiliated with or benefiting from a social security scheme.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 18
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 15

•- Patient with history of heart disease
•- Patient with coronary stenosis of more than 50% on coronary angiography or CT
•- Patient with a formal or relative contraindication for performing a PET / CT scan at 68Ga DOTATOC
•- Impossibility of performing a PET scan at 68Ga-DOTATOC (agitated, confused patient ...). Unable to schedule the PET / CT exam at 68Ga-DOTATOC within a maximum of 72 hours after the MRI.
•- Patient currently being treated with corticosteroids prior to the 68Ga-DOTATOC PET / CT examination.
•- Patient treated with a somatostatin analogue.
•- Patient with Cushing's syndrome
•- Pregnant woman, likely to be pregnant or breastfeeding
•- A person of full age who is the subject of a legal protection measure (guardianship, curatorship, safeguard of justice)
•- A person of full age who is unable to express their consent
•- Person deprived of their liberty by a judicial or administrative decision
•- Person undergoing psychiatric care under Articles L. 3212-1 and L. 3213-1

发起方

CHRU DE NANCY